We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Align Technology, Henry Schein, McKesson Corp and Becton, Dickinson and Co
Read MoreHide Full Article
For Immediate Release
Chicago, IL – February 19, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Align Technology, Inc. (ALGN - Free Report) , Henry Schein, Inc. (HSIC - Free Report) , McKesson Corporation (MCK - Free Report) and Becton, Dickinson and Company (BDX - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
4 Dental Stocks to Watch on Likely Industry Turnaround
Demand for dental healthcare seems to be picking up from the slump in visits to clinics and hospitals last year due to the outbreak of COVID-19. This is a major positive for the dental supplies market. Notably, per a report by Grand View Research, the global dental equipment market was valued at $5.4 billion in 2020 and is estimated to witness a CAGR of 12.1% from 2021 to 2028.
The report mentioned that some of the factors that can contribute to the market's growth include an expanding geriatric population that is suffering from oral diseases as well as government initiatives to boost public oral health care.
Moreover, the report stated that the introduction of more efficient and advanced equipment is expected to provide a further boost to the market. Meanwhile, dental disorders like "periodontal disease, oral cancer, and environmental injuries resulting from Oro-dental trauma" are also expected to help the market grow.
Notably, the COVID-19 pandemic proved to be a hindrance for the market last year. The report mentioned that routine dental care was largely unavailable as many dental procedures had to be closed on grounds of being elective procedures. Even though the cost of availing dental care might rise, the report stated that the market is estimated to see positive changes in offering safe care.
Notably, the report mentioned that North America is estimated to emerge as the most promising market during the forecast period. Some of the factors which might contribute to this growth include a growing geriatric population as well as a strong medical infrastructure along with well-established reimbursement policies.
In fact, the report stated that North America dominated the dental equipment market in 2020 and accounted for the highest revenue share of 38.2%. Notably, a survey conducted by the American Dental Association last year found that 99.7% of the respondent dentists had implemented "enhanced infection prevention and control procedures." This included measures like disinfecting equipment and surfaces, checking the temperature of patients and staff, screening of patients for COVID-19, and so on. Moreover, 99.6% of dentists reported the use of personal protective equipment while treating patients.
4 Stocks to Watch Out For
The dental equipment market seems poised to witness growth going forward as dental healthcare continues to recover from the slump brought about by the COVID-19 pandemic. Hence, this seems to be a prudent time to look at names focused on dental supplies that stand to benefit. We have picked four such stocks that carry a Zacks Rank #1 (Strong Buy) or 3 (Hold). You can see the complete list of today's Zacks #1 Rank stocks here.
Align Technology is a medical device company that designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. The company currently has a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings has climbed 12.3% over the past 60 days. The company's expected earnings growth rate for the current year is 71.8%.
Henry Schein provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. The company's Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials and so on. It currently has a Zacks Rank #3.
The Zacks Consensus Estimate for its current-year earnings has risen 1.4% over the past 90 days. The company's expected earnings growth rate for the next five years is 9.1%.
McKesson Corp. provides pharmaceuticals and medical supplies in the United States and internationally. Notably, the company offers its range of premier dental products. It currently has a Zacks Rank #3. The Zacks Consensus Estimate for its current-year earnings has moved 5.1% north over the past 60 days. The company's expected earnings growth rate for the current year is 13.7%.
Becton, Dickinson and Co. develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. Notably, the company offers various dental supplies like syringes and needles, surface cleaners and disinfectants, patient monitoring products, endodontic products and so on. It currently has a Zacks Rank #3.
The Zacks Consensus Estimate for its current-year earnings has moved up 2.3% over the past 60 days. The company's expected earnings growth rate for the current year is 25.4%.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Align Technology, Henry Schein, McKesson Corp and Becton, Dickinson and Co
For Immediate Release
Chicago, IL – February 19, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Align Technology, Inc. (ALGN - Free Report) , Henry Schein, Inc. (HSIC - Free Report) , McKesson Corporation (MCK - Free Report) and Becton, Dickinson and Company (BDX - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
4 Dental Stocks to Watch on Likely Industry Turnaround
Demand for dental healthcare seems to be picking up from the slump in visits to clinics and hospitals last year due to the outbreak of COVID-19. This is a major positive for the dental supplies market. Notably, per a report by Grand View Research, the global dental equipment market was valued at $5.4 billion in 2020 and is estimated to witness a CAGR of 12.1% from 2021 to 2028.
The report mentioned that some of the factors that can contribute to the market's growth include an expanding geriatric population that is suffering from oral diseases as well as government initiatives to boost public oral health care.
Moreover, the report stated that the introduction of more efficient and advanced equipment is expected to provide a further boost to the market. Meanwhile, dental disorders like "periodontal disease, oral cancer, and environmental injuries resulting from Oro-dental trauma" are also expected to help the market grow.
Notably, the COVID-19 pandemic proved to be a hindrance for the market last year. The report mentioned that routine dental care was largely unavailable as many dental procedures had to be closed on grounds of being elective procedures. Even though the cost of availing dental care might rise, the report stated that the market is estimated to see positive changes in offering safe care.
Notably, the report mentioned that North America is estimated to emerge as the most promising market during the forecast period. Some of the factors which might contribute to this growth include a growing geriatric population as well as a strong medical infrastructure along with well-established reimbursement policies.
In fact, the report stated that North America dominated the dental equipment market in 2020 and accounted for the highest revenue share of 38.2%. Notably, a survey conducted by the American Dental Association last year found that 99.7% of the respondent dentists had implemented "enhanced infection prevention and control procedures." This included measures like disinfecting equipment and surfaces, checking the temperature of patients and staff, screening of patients for COVID-19, and so on. Moreover, 99.6% of dentists reported the use of personal protective equipment while treating patients.
4 Stocks to Watch Out For
The dental equipment market seems poised to witness growth going forward as dental healthcare continues to recover from the slump brought about by the COVID-19 pandemic. Hence, this seems to be a prudent time to look at names focused on dental supplies that stand to benefit. We have picked four such stocks that carry a Zacks Rank #1 (Strong Buy) or 3 (Hold). You can see the complete list of today's Zacks #1 Rank stocks here.
Align Technology is a medical device company that designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. The company currently has a Zacks Rank #1. The Zacks Consensus Estimate for its current-year earnings has climbed 12.3% over the past 60 days. The company's expected earnings growth rate for the current year is 71.8%.
Henry Schein provides health care products and services to office-based dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. The company's Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials and so on. It currently has a Zacks Rank #3.
The Zacks Consensus Estimate for its current-year earnings has risen 1.4% over the past 90 days. The company's expected earnings growth rate for the next five years is 9.1%.
McKesson Corp. provides pharmaceuticals and medical supplies in the United States and internationally. Notably, the company offers its range of premier dental products. It currently has a Zacks Rank #3. The Zacks Consensus Estimate for its current-year earnings has moved 5.1% north over the past 60 days. The company's expected earnings growth rate for the current year is 13.7%.
Becton, Dickinson and Co. develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. Notably, the company offers various dental supplies like syringes and needles, surface cleaners and disinfectants, patient monitoring products, endodontic products and so on. It currently has a Zacks Rank #3.
The Zacks Consensus Estimate for its current-year earnings has moved up 2.3% over the past 60 days. The company's expected earnings growth rate for the current year is 25.4%.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.